Loading
companiesCompany
Cellares
Cellares builds the Cell Shuttle, a fully automated 'smart factory' for cell therapies, with BMS and Kite as partners.
Overview
Cellares, based in South San Francisco, builds the Cell Shuttle, a fully automated smart factory for cell therapies, with Bristol Myers Squibb and Kite as partners. It describes itself as an integrated development and manufacturing organisation, the Cell Shuttle automates the CAR-T process end to end, it raised a 255 million dollar Series C in 2023, signed manufacturing agreements with BMS in 2024 and with Kite, and has smart factories under construction in New Jersey and Japan. OnCo links it to closed automated cell-therapy manufacturing and to point-of-care and decentralised cell manufacturing. Whether automation cuts the cost and turnaround of CAR-T enough to widen access is the question its factories will answer. The closed manufacturing technology page carries the wider picture.
Headquarters
South San Francisco, CA, US
Manufacturing
Capacity map- Cellares Smart Factory South San Francisco, California, USCell therapy
Type
Website
Similar pages
- CompanyMiltenyi Biotec
Shares Closed automated cell-therapy manufacturing, Point-of-care and decentralised cell manufacturing, Autologous CAR-T manufacturing, batch by batch and the tag supporting.
- CompanyCytiva (Danaher)
Shares Closed automated cell-therapy manufacturing, Autologous CAR-T manufacturing, batch by batch and the tag supporting.
- CompanyTerumo Blood and Cell Technologies
Shares Closed automated cell-therapy manufacturing and the tag supporting.
- CompanyGalapagos
Shares Point-of-care and decentralised cell manufacturing and the tag supporting.
- TechnologyCell-therapy orchestration and chain-of-identity software
Shares Autologous CAR-T manufacturing, batch by batch and the tag supporting.
- TechnologyCell-therapy release and potency testing
Shares Closed automated cell-therapy manufacturing, Autologous CAR-T manufacturing, batch by batch and the tag supporting.
- CompanyLonza
Shares Closed automated cell-therapy manufacturing, Autologous CAR-T manufacturing, batch by batch and the tag supporting.
- TechnologyApheresis and starting-material collection
Shares Autologous CAR-T manufacturing, batch by batch and the tag supporting.